Headline News about Boston Scientific
Boston Scientific Recalls Faulty Pacemakers Due To Risk of Incorrect Transition To Safety Mode
August 06, 2021
Via Benzinga
Topics
Product Recall
Via Benzinga
Via Benzinga
The Daily Biotech Pulse: FDA Rejection For Protalix, Amgen Q1 Trail Estimates, Pfizer Goes Shopping
April 28, 2021
Via Benzinga
Exposures
Product Safety
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|